Experimentally, upregulation of SOCS-1 and -3 in the liver leads to insulin resistance through several mechanisms, including degradation of IRS1 and IRS2 inhibition of insulin receptor kinase activity, and downregulation of IFN-associated innate immunity [16–18]. This evidence concerns the gene IRS1 and Insulin resistance.